Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.
Fiche publication
Date publication
février 2019
Journal
Diabetes & metabolism
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno, Pr COTTIN Yves
Tous les auteurs :
Benalia M, Zeller M, Mouhat B, Guenancia C, Yameogo V, Greco C, Yao H, Maza M, Vergès B, Cottin Y
Lien Pubmed
Résumé
- In patients with type 2 diabetes (T2D), glycaemic variability (GV), another component of glycaemic abnormalities, is a novel potentially aggravating factor for coronary artery disease (CAD).
Mots clés
Acute myocardial infarction, Coronary artery disease, Glycaemic variability, Glycated haemoglobin A1c, Type 2 diabetes
Référence
Diabetes Metab.. 2019 Feb 11;: